Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Vues
• 06/15/23
0
0
Intégrer
administrator
Les abonnés
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires